Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PJP vs PSCH overlap: 18% of top holdings shared

Bottom line

How much do PJP and PSCH overlap?

18% of their top holdings overlap by weight. 4 securities appear in both funds' top 25, making up 19.8% of PJP's assets and 35.6% of PSCH's. They are substantially different portfolios, so owning both adds real diversification.

PSCH holds far more positions (81 vs 33), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PJPPSCH
Weight overlap (top 25)18%
Shared holdings4
Weight in shared holdings19.8%35.6%
Total positions3381
Expense ratio0.58%0.29%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings PJP and PSCH have in common

Holding% of PJP% of PSCHOverlap
Invesco Private Prime Fund7.93%21.48%7.93%
Corcept Therapeutics Inc.4.96%3.47%3.47%
Invesco Private Government Fund3.73%8.27%3.73%
Ligand Pharmaceuticals Inc.3.20%2.43%2.43%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PJP

  1. Abbott Laboratories — 5.67%
  2. AbbVie Inc. — 5.48%
  3. Amgen Inc. — 5.33%
  4. Johnson & Johnson — 5.18%
  5. Merck & Co., Inc. — 5.06%
  6. Eli Lilly and Co. — 5.02%
  7. Gilead Sciences, Inc. — 4.53%
  8. Pfizer Inc. — 4.50%
  9. Amneal Pharmaceuticals, Inc. — 3.75%
  10. Liquidia Corp. — 3.66%
  11. Travere Therapeutics, Inc. — 3.30%
  12. Regeneron Pharmaceuticals, Inc. — 3.14%
  13. Harmony Biosciences Holdings, Inc. — 3.06%
  14. Bristol-Myers Squibb Co. — 2.94%
  15. Viatris Inc. — 2.83%

Only in PSCH

  1. Molina Healthcare, Inc. — 4.77%
  2. BrightSpring Health Services, Inc. — 4.35%
  3. Krystal Biotech, Inc. — 4.25%
  4. Alkermes PLC — 3.71%
  5. Glaukos Corp. — 3.17%
  6. PTC Therapeutics, Inc. — 3.16%
  7. Protagonist Therapeutics, Inc. — 3.12%
  8. Teleflex Inc. — 3.03%
  9. TG Therapeutics, Inc. — 2.75%
  10. Indivior Pharmaceuticals, Inc. — 2.40%
  11. RadNet, Inc. — 2.06%
  12. Merit Medical Systems, Inc. — 1.99%
  13. Veracyte, Inc. — 1.95%
  14. Catalyst Pharmaceuticals, Inc. — 1.92%
  15. Organon & Co. — 1.85%

Asset mix

Asset typePJPPSCH
Stocks99.9%99.9%
Cash & short-term funds11.8%29.8%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryPJPPSCH
US106.5%125.2%
IE5.2%4.5%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PJP and PSCH overlap?
About 18% by weight. 4 securities appear in both funds' top 25 holdings; they make up 19.8% of PJP's assets and 35.6% of PSCH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do PJP and PSCH have in common?
The largest shared holdings are Invesco Private Prime Fund, Invesco Private Government Fund, Corcept Therapeutics Inc., Ligand Pharmaceuticals Inc..
Should I own both PJP and PSCH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, PJP or PSCH?
PSCH is broader, with 81 positions versus 33 for PJP. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.